Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 19% ± 3% | |
| astrocyte | 5 studies | 22% ± 5% | |
| epithelial cell | 4 studies | 25% ± 3% | |
| glutamatergic neuron | 4 studies | 39% ± 14% | |
| oligodendrocyte precursor cell | 4 studies | 25% ± 6% | |
| oligodendrocyte | 4 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 37% ± 6% | |
| interneuron | 3 studies | 34% ± 18% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2026.61 | 1445 / 1445 | 100% | 47.85 | 183 / 183 |
| breast | 100% | 2197.77 | 459 / 459 | 100% | 52.81 | 1115 / 1118 |
| stomach | 100% | 1677.81 | 359 / 359 | 100% | 35.23 | 285 / 286 |
| prostate | 100% | 2033.68 | 245 / 245 | 100% | 35.28 | 500 / 502 |
| uterus | 100% | 2125.32 | 170 / 170 | 99% | 34.84 | 456 / 459 |
| ovary | 100% | 1921.77 | 180 / 180 | 99% | 35.43 | 427 / 430 |
| lung | 100% | 1775.17 | 577 / 578 | 99% | 36.56 | 1147 / 1155 |
| intestine | 100% | 1916.52 | 966 / 966 | 99% | 33.62 | 521 / 527 |
| thymus | 100% | 1856.92 | 653 / 653 | 99% | 28.06 | 598 / 605 |
| pancreas | 100% | 1251.38 | 327 / 328 | 99% | 24.18 | 176 / 178 |
| bladder | 100% | 1967.86 | 21 / 21 | 98% | 28.28 | 495 / 504 |
| adrenal gland | 100% | 2647.81 | 258 / 258 | 97% | 23.99 | 222 / 230 |
| brain | 99% | 1222.92 | 2604 / 2642 | 98% | 20.92 | 689 / 705 |
| skin | 100% | 2810.83 | 1809 / 1809 | 96% | 25.52 | 452 / 472 |
| kidney | 100% | 1168.54 | 89 / 89 | 96% | 21.69 | 862 / 901 |
| liver | 100% | 1280.83 | 226 / 226 | 92% | 15.85 | 373 / 406 |
| adipose | 100% | 2129.18 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1953.82 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1719.04 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 41.35 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 15.88 | 1 / 1 |
| muscle | 99% | 870.95 | 792 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 861.26 | 833 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 23.82 | 28 / 29 |
| peripheral blood | 93% | 1223.38 | 863 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 14.34 | 71 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0070682 | Biological process | proteasome regulatory particle assembly |
| GO_0000502 | Cellular component | proteasome complex |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0008540 | Cellular component | proteasome regulatory particle, base subcomplex |
| GO_0022624 | Cellular component | proteasome accessory complex |
| GO_0005515 | Molecular function | protein binding |
| Gene name | PSMD5 |
| Protein name | 26S proteasome non-ATPase regulatory subunit 5 (26S protease subunit S5 basic) (26S proteasome subunit S5B) Proteasome 26S subunit, non-ATPase 5 |
| Synonyms | KIAA0072 |
| Description | FUNCTION: Acts as a chaperone during the assembly of the 26S proteasome, specifically of the base subcomplex of the PA700/19S regulatory complex (RC). In the initial step of the base subcomplex assembly is part of an intermediate PSMD5:PSMC2:PSMC1:PSMD2 module which probably assembles with a PSMD10:PSMC4:PSMC5:PAAF1 module followed by dissociation of PSMD5. . |
| Accessions | ENST00000373920.6 F2Z3J2 Q4VXH0 ENST00000373904.5 [Q16401-2] Q16401 ENST00000210313.8 [Q16401-1] ENST00000476949.1 ENST00000625444.1 |
